These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6174444)

  • 1. Acute responses to arterial pressure and plasma renin activity to converting enzyme inhibition (SQ 20,881) in serially studied dogs with neonatally-induced coarctation hypertension.
    Bagby SP
    Hypertension; 1982; 4(1):146-54. PubMed ID: 6174444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine neonatally induced coarctation hypertension in the second year. Variably hyperresponsive plasma renin activity.
    Bagby SP; Baur GM
    Hypertension; 1983; 5(3):328-35. PubMed ID: 6341218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic CEI alters effect of low Na+ diet in normal and coarcted pups. I. BP, renin, and GFR.
    Bagby SP; Fuchs E
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R523-30. PubMed ID: 2537042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro determinants of plasma renin activity in serially-studied inbred dogs with neonatally induced coarctation hypertension: renin reactivity, renin substrate, and renin concentration.
    Bagby SP; McDonald WJ; Gray DK
    Clin Exp Hypertens (1978); 1981; 3(3):455-75. PubMed ID: 7018860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups.
    Bagby SP; Fuchs EF
    Hypertension; 1989 Feb; 13(2):91-101. PubMed ID: 2536643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic CEI alters effect of low Na+ diet in normal and coarcted pups. II. Na+ and H2O balance.
    Bagby SP; Fuchs E
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R531-40. PubMed ID: 2537043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus-response curve of the renal baroreceptor: effect of converting enzyme inhibition and changes in salt intake.
    Farhi ER; Cant JR; Paganelli WC; Dzau VJ; Barger AC
    Circ Res; 1987 Nov; 61(5):670-7. PubMed ID: 3311448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular volume expansion and delayed resolution of hypertension after canine aortic coarctectomy.
    Wickre CG; Baur GM; Wong J; Woodruff J; Bagby SP
    Life Sci; 1983 Mar; 32(11):1197-206. PubMed ID: 6339851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin I converting enzyme inhibitor, SQ 14225, on renin production and release.
    Saruta T; Eguchi T; Yasui T; Nagahama S; Nakamura R; Kato E
    Nephron; 1981; 29(5-6):265-9. PubMed ID: 6172718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
    Case DB; Wallace JM; Keim HJ; Weber MA; Sealey JE; Laragh JH
    N Engl J Med; 1977 Mar; 296(12):641-6. PubMed ID: 190537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.
    Ploth DW; Rudulph J; LaGrange R; Navar LG
    J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs.
    Navar LG; Jirakulsomchok D; Bell PD; Thomas CE; Huang WC
    Hypertension; 1982; 4(1):58-68. PubMed ID: 6174445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.
    Wang JL; Cheng HF; Harris RC
    Hypertension; 1999 Jul; 34(1):96-101. PubMed ID: 10406830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of renal perfusion and the renal pressor system in dogs with chronic aortic coarctation.
    Bagby SP; McDonald WJ; Strong DW; Porter GA; Bennett WM; Bonchek LI
    Circ Res; 1975 Nov; 37(5):615-20. PubMed ID: 1192558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron responses to converting enzyme inhibition in non-clipped kidney of Goldblatt hypertensive rat at normotensive pressures.
    Huang WC; Jackson CA; Navar LG
    Kidney Int; 1985 Aug; 28(2):128-34. PubMed ID: 3009954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.